Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine.

Oo ZY, Proctor M, Stevenson AJ, Nazareth D, Fernando M, Daignault SM, Lanagan C, Walpole S, Bonazzi V, Škalamera D, Snell C, Haass NK, Larsen JE, Gabrielli B.

Mol Oncol. 2019 Jul;13(7):1503-1518. doi: 10.1002/1878-0261.12497. Epub 2019 Jun 14.

2.

Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo.

Oo ZY, Stevenson AJ, Proctor M, Daignault SM, Walpole S, Lanagan C, Chen J, Škalamera D, Spoerri L, Ainger SA, Sturm RA, Haass NK, Gabrielli B.

Clin Cancer Res. 2018 Jun 15;24(12):2901-2912. doi: 10.1158/1078-0432.CCR-17-2701. Epub 2018 Mar 13.

3.

Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer.

Gabrielli B, Bokhari F, Ranall MV, Oo ZY, Stevenson AJ, Wang W, Murrell M, Shaikh M, Fallaha S, Clarke D, Kelly M, Sedelies K, Christensen M, McKee S, Leggatt G, Leo P, Skalamera D, Soyer HP, Gonda TJ, McMillan NA.

Mol Cancer Ther. 2015 Dec;14(12):2753-61. doi: 10.1158/1535-7163.MCT-15-0506. Epub 2015 Oct 29.

4.

Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells.

Li Y, Kandasamy K, Chuah JK, Lam YN, Toh WS, Oo ZY, Zink D.

Mol Pharm. 2014 Jul 7;11(7):1982-90. doi: 10.1021/mp400637s. Epub 2014 Feb 20.

PMID:
24495215
5.

A novel design of bioartificial kidneys with improved cell performance and haemocompatibility.

Oo ZY, Kandasamy K, Tasnim F, Zink D.

J Cell Mol Med. 2013 Apr;17(4):497-507. doi: 10.1111/jcmm.12029. Epub 2013 Mar 11.

6.

The performance of primary human renal cells in hollow fiber bioreactors for bioartificial kidneys.

Oo ZY, Deng R, Hu M, Ni M, Kandasamy K, bin Ibrahim MS, Ying JY, Zink D.

Biomaterials. 2011 Dec;32(34):8806-15. doi: 10.1016/j.biomaterials.2011.08.030. Epub 2011 Aug 27.

PMID:
21872923

Supplemental Content

Support Center